Back to Search

BBIO

BridgeBio Pharma, Inc. Common Stock
Data: 2026-07-31
$80.09
Price
-2.50%
Change
$93.42
52W High
$42.09
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Quick Stats
Jul 31, 2026

55.7

AI Score

HOLD

0.52

Volume Ratio

Aug 04, 2026

Next Earnings

20

+ve Days (30d)

10

-ve Days (30d)

BBIO Stock Summary

Last updated Jul 31, 2026

BBIO is currently trading at $80.09, positioned above its 200-day moving average of $71.38, indicating a long-term uptrend. The stock has a 52-week range of $42.0901 to $93.415.

Technical Analysis: The 50-day moving average stands at $74.12, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 50.848, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.024, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates BBIO at 55.7/100 with a HOLD recommendation.

BBIO (BridgeBio Pharma, Inc. Common Stock) Indicators

Last updated Jul 31, 2026

Indicator Value
RSI(14) 50.848
CMF (20) 0.024
ROC (10) -1.585
ADX (14) 35.008
Indicator Value
MACD (12,26,9) 2.366
AROONOSC (14) 42.857
WILLAMS %R (14) -84.877
MFI (14) 45.21
BBIO Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

BBIO Price vs Max Options Open Interest
BBIO Max Change In Options Open Interest

BBIO Options - Sort by Max open Interest (near term)

2nd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

BBIO Daily Out of Money Options - Sort by Max open Interest (near term)

2nd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

BBIO Daily In the Money Options - Sort by Max open Interest (near term)

2nd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

BBIO Most Active Options by Volume(near term)

2nd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

BridgeBio Pharma, Inc. Common Stock is above both the 50 Day and 200 Day SMA which is considered Bullish.

BBIO Moving Averages Analysis

BridgeBio Pharma, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jul 31, 2026

BridgeBio Pharma, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jul 31, 2026

BBIO (BridgeBio Pharma, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Jul 31, 2026

Days MA
10 82.83
20 82.49
30 78.7
50 74.12
100 72.74
200 71.38

BBIO Fundamental Analysis

P/E (Forward) --
P/E (Trailing) --
Market Cap ($) 16.1 billion
Earnings/Share ($) -3.67
Net Profit Margin (%) -1.2442
Dividend/Share ($) --
EPS Estimate Current Year ($) -2.1412
EPS Estimate Next Year ($) 0.5687
WallStreet Target Price ($) 105.26
Most Recent Quarter